Global Diagnostics - G2 Intelligence

New Company Formed to Help Improve Access to Diagnostics

The creation of Global Access Diagnostics aims to expand affordable access to quality tests around the world.

The IVDR will bring around 80 percent of in vitro diagnostic medical devices under the control of so-called Notified Bodies.

While the much-delayed IVDR will take effect at the end of the month, it will be rolled out gradually.

In CE-IVD-related announcements made over last week, the majority involved the cancer testing market.

According to a recent report, this market will see almost seven percent annual growth over the next five years, reaching US $1.29 billion in 2026.

Start a Free Trial for immediate access to this article

Already a member? Log in here